Zacks Research Issues Pessimistic Estimate for CLB Earnings

Core Laboratories Inc. (NYSE:CLB) – Analysts at Zacks Research lowered their Q2 2025 earnings estimates for shares of Core Laboratories in a research report issued to clients and investors on Wednesday, March 26th. Zacks Research analyst T. Saha now anticipates that the oil and gas company will earn $0.21 per share for the quarter, down from their previous forecast of $0.25. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.34 EPS and FY2027 earnings at $1.28 EPS.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%.

Separately, Citigroup raised Core Laboratories from a “sell” rating to a “neutral” rating and increased their target price for the company from $15.00 to $16.00 in a report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating and four have given a hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $17.50.

Core Laboratories Stock Up 0.5 %

CLB opened at $15.47 on Friday. The company has a market cap of $724.41 million, a PE ratio of 23.44, a price-to-earnings-growth ratio of 0.99 and a beta of 2.38. Core Laboratories has a twelve month low of $12.95 and a twelve month high of $25.13. The company has a 50-day moving average price of $16.52 and a 200 day moving average price of $18.10. The company has a quick ratio of 1.71, a current ratio of 2.32 and a debt-to-equity ratio of 0.49.

Institutional Trading of Core Laboratories

Several large investors have recently added to or reduced their stakes in CLB. State Street Corp boosted its position in shares of Core Laboratories by 2.9% during the 3rd quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock valued at $36,597,000 after acquiring an additional 56,187 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Core Laboratories by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company’s stock valued at $19,521,000 after purchasing an additional 7,721 shares during the last quarter. Boston Trust Walden Corp grew its stake in shares of Core Laboratories by 2.7% in the 4th quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company’s stock valued at $10,686,000 after buying an additional 16,503 shares during the period. Barclays PLC increased its holdings in shares of Core Laboratories by 288.2% during the 3rd quarter. Barclays PLC now owns 83,570 shares of the oil and gas company’s stock worth $1,549,000 after buying an additional 62,042 shares during the last quarter. Finally, Amundi raised its position in shares of Core Laboratories by 194.8% during the 4th quarter. Amundi now owns 32,968 shares of the oil and gas company’s stock valued at $600,000 after buying an additional 21,783 shares during the period. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Core Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Monday, February 10th were issued a $0.01 dividend. The ex-dividend date was Monday, February 10th. This represents a $0.04 annualized dividend and a dividend yield of 0.26%. Core Laboratories’s dividend payout ratio is presently 6.06%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.